首页> 外文OA文献 >Plasminogen Tochigi: inactive plasmin resulting from replacement of alanine-600 by threonine in the active site.
【2h】

Plasminogen Tochigi: inactive plasmin resulting from replacement of alanine-600 by threonine in the active site.

机译:纤溶酶To木:在活性部位由苏氨酸替代丙氨酸600导致的纤溶酶失活。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Structural studies on a hereditarily abnormal plasminogen, plasminogen Tochigi, have been performed to identify the difference responsible for its lack of proteolytic activity. The plasminogen sample used was from a heterozygote and thus consisted of apparently equal amounts of normal and defective plasminogen molecules. Amino acid sequence analysis of a tryptic peptide isolated from the abnormal plasminogen indicated that Ala-600 (equivalent to Ala-55 in the chymotrypsin numbering system) had been replaced by Thr. No other substitutions in the active-site residues--namely, His-57, Asp-102, and Ser-195--were found. Molecular models for chymotrypsin and the bovine trypsin-pancreatic trypsin inhibitor complex indicate that Ala-55 is very near the active-site His. The Thr at position 55 in plasminogen (plasmin) Tochigi may perturb His-57 such that the proton transfers associated with the normal catalytic process cannot occur in the abnormal plasmin.
机译:已经对遗传异常的纤溶酶原,To木纤溶酶原进行了结构研究,以鉴定导致其缺乏蛋白水解活性的差异。所使用的纤溶酶原样品来自杂合子,因此由明显等量的正常和有缺陷的纤溶酶原分子组成。从异常纤溶酶原分离的胰蛋白酶肽的氨基酸序列分析表明,Ala-600(相当于胰凝乳蛋白酶编号系统中的Ala-55)已被Thr取代。在活性位点残基中未发现其他取代,即His-57,Asp-102和Ser-195。胰凝乳蛋白酶和牛胰蛋白酶-胰胰蛋白酶抑制剂复合物的分子模型表明,Ala-55非常靠近活性位点His。纤溶酶原(纤溶酶)To木中第55位的Thr可能会干扰His-57,从而在正常的纤溶酶中不会发生与正常催化过程相关的质子转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号